United States Court of Appeals For the First Circuit
No. 23-1125
UNITED STATES OF AMERICA,
Appellee,
v.
JOSÉ A. VEGA-FIGUEROA, a/k/a Pito Casco,
Defendant, Appellant.
APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF PUERTO RICO
[Hon. Daniel R. Domínguez, U.S. District Judge]
Before
Barron, Chief Judge, Gelpí and Montecalvo, Circuit Judges.
Frank D. Inserni Milam for appellant.
Jeniffer Vélez Pérez, Assistant United States Attorney, with whom W. Stephen Muldrow, United States Attorney, and Mariana E. Bauzá-Almonte, Assistant United States Attorney, Chief, Appellate Division, were on brief, for appellee.
June 4, 2025 GELPÍ, Circuit Judge. Defendant-Appellant José A.
Vega-Figueroa ("Vega") is serving multiple life sentences for his
role in a 1990s drug-trafficking operation. In February 2021,
Vega sought release from prison by moving for compassionate
release. The district court denied that motion and Vega now
appeals, contending that the district court neither adequately
addressed his "extraordinary and compelling" reasons for release
nor adequately addressed the 18 U.S.C. § 3553(a) sentencing
factors. For the reasons that follow, we affirm.
I. Background
Vega has appeared before this court many times. See,
e.g., United States v. Vega-Figueroa, 234 F.3d 744, 747 (1st Cir.
2000); United States v. Vega-Figueroa, No. 09-1077 (1st Cir.
July 29, 2009); United States v. Vega-Figueroa, No. 12-1754 (1st
Cir. Aug. 8, 2012); United States v. Vega-Figueroa, No. 14-1247
(1st Cir. Mar. 31, 2015); United States v. Vega-Figueroa, No.
18-1906 (1st Cir. Aug. 26, 2019). Consequently, we assume the
parties' familiarity with much of the procedural and factual
- 2 - background and recite here only the information necessary to
explain our decision.1
In 1994, Vega was charged in the Superior Court of Puerto
Rico, Carolina Section, with ten counts related to various criminal
offenses. See Vega-Figueroa, slip op. at 1. Those charges
included, in relevant part: (1) unlawful possession, use, and
transportation of several guns; and (2) two counts of first-degree
murder for the deaths of Reynaldo Colón González ("Colón González")
and Melvin Flores-Montalvo ("Flores-Montalvo"). Id. On
October 11, 1995, a jury acquitted Vega of all charges. Id.
In 1997, however, a federal grand jury returned an
indictment against Vega. Id. at 2. It was alleged that Vega,
along with a co-defendant, was "in charge of an extensive criminal
enterprise involving the sale and distribution of heroin, cocaine,
crack cocaine, and marijuana" in Puerto Rico between 1990 and 1997.
Vega-Figueroa, 234 F.3d at 748. As the district court in that
case described it, the enterprise was a "very dangerous and violent
drug gang." See Vega-Figueroa, slip op. at 4. The indictment
charged Vega with various counts, including: (1) aiding and
abetting in a continuing criminal enterprise; (2) conspiring to
distribute in excess of five kilograms of heroin, in excess of
1The district court's Opinion and Order provides a more fulsome history. See United States v. Vega-Figueroa, No. 3:97-cr-00072-CVR, slip op. at 1-4 (D.P.R. Dec. 12, 2022).
- 3 - five kilograms of cocaine, and in excess of 100 kilograms of
marijuana; and (3) the unlawful use of firearms during and in
relation to a drug-trafficking offense. The indictment also listed
the aforementioned murders of Colón González and Flores-Montalvo
as overt acts in furtherance of the conspiracy. After a thirty-day
trial, the federal jury found Vega guilty on all counts.
Following the verdict, a Presentence Investigation
Report ("PSR") was prepared; it set forth a base offense level of
43. The PSR included homicide-related facts, which were the basis
for an increase in Vega's sentencing exposure under the
then-mandatory United States Sentencing Guidelines. The district
court sentenced Vega on February 19, 1999. The district court's
sentence included concurrent life sentences, one each as to Counts
One and Two, and a five-year term as to Count Three.
Shortly after sentencing, Vega appealed his conviction
and sentence to this court. See Vega-Figueroa, 234 F.3d 744. In
that appeal, Vega raised ten issues, including various evidentiary
challenges. Id. at 747-57. We affirmed Vega's conviction after
evaluating his contentions. Id. at 758. Following our decision,
Vega unsuccessfully continued to seek relief from his sentence.
See, e.g., Mot. for Retroactive Appl. of Sentencing Guidelines,
No. 3:97-cr-00072-CVR (D.P.R. May 14, 2008), ECF No. 758; Mot. to
Vacate Sentence, No. 3:97-cr-00072-CVR (D.P.R. Nov. 12, 2013), ECF
- 4 - No. 917; Mot. to Validate, No. 3:97-cr-00072-CVR (D.P.R. June 28,
2016), ECF No. 1014.
The procedural history of the present appeal is
comparatively short. Vega filed a request for compassionate
release with the Bureau of Prisons ("BOP") on May 11, 2020. There,
he emphasized his increased risk of complications from COVID-19,
given his preexisting medical conditions. On July 20, 2020, the
Warden of FCI Coleman -- FCI Coleman being the location where Vega
is incarcerated -- denied Vega's request, citing the BOP's
"extraordinary measures to contain the spread of COVID-19."2 Vega
then moved for compassionate release in the District of Puerto
Rico on February 8, 2021.
Vega's motion was brought pursuant to 18 U.S.C.
§ 3582(c)(1)(a), the provision governing sentence reductions
(colloquially known as the compassionate release provision). Vega
argued that he was entitled to relief due, in part, to the BOP's
allegedly negligent monitoring and treatment of his type 2 diabetes
and his increased risk of COVID-19-related complications due to
his diabetes. He also emphasized his "having been placed in
jeopardy twice for the same conduct on like charges (murder in the
2 Vega refers to the prison where he is housed as "FCC Coleman," while the government refers to it as "FCI Coleman." Federal Correctional Institution, Coleman, "FCI Coleman," is an Institution located within the Federal Correctional Complex, Coleman, "FCC Coleman." We adopt "FCI Coleman" here.
- 5 - first degree)." Finally, Vega asserted that his rehabilitation
efforts, analyzed under the 18 U.S.C. § 3553(a) sentencing
factors, supported a sentence reduction.
The government opposed Vega's motion, arguing that Vega
had presented neither extraordinary and compelling reasons for
compassionate release nor evidence that he was not a danger to the
community. The government pressed that Vega's health conditions
did not rise to the level of severity required under the U.S.S.G.
§ 1B1.13 policy statement.3 Further, in arguing that Vega
continued to present a danger to the community, the government
highlighted Vega's central role in the "dangerous and violent"
drug gang.4
Free access — add to your briefcase to read the full text and ask questions with AI
United States Court of Appeals For the First Circuit
No. 23-1125
UNITED STATES OF AMERICA,
Appellee,
v.
JOSÉ A. VEGA-FIGUEROA, a/k/a Pito Casco,
Defendant, Appellant.
APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF PUERTO RICO
[Hon. Daniel R. Domínguez, U.S. District Judge]
Before
Barron, Chief Judge, Gelpí and Montecalvo, Circuit Judges.
Frank D. Inserni Milam for appellant.
Jeniffer Vélez Pérez, Assistant United States Attorney, with whom W. Stephen Muldrow, United States Attorney, and Mariana E. Bauzá-Almonte, Assistant United States Attorney, Chief, Appellate Division, were on brief, for appellee.
June 4, 2025 GELPÍ, Circuit Judge. Defendant-Appellant José A.
Vega-Figueroa ("Vega") is serving multiple life sentences for his
role in a 1990s drug-trafficking operation. In February 2021,
Vega sought release from prison by moving for compassionate
release. The district court denied that motion and Vega now
appeals, contending that the district court neither adequately
addressed his "extraordinary and compelling" reasons for release
nor adequately addressed the 18 U.S.C. § 3553(a) sentencing
factors. For the reasons that follow, we affirm.
I. Background
Vega has appeared before this court many times. See,
e.g., United States v. Vega-Figueroa, 234 F.3d 744, 747 (1st Cir.
2000); United States v. Vega-Figueroa, No. 09-1077 (1st Cir.
July 29, 2009); United States v. Vega-Figueroa, No. 12-1754 (1st
Cir. Aug. 8, 2012); United States v. Vega-Figueroa, No. 14-1247
(1st Cir. Mar. 31, 2015); United States v. Vega-Figueroa, No.
18-1906 (1st Cir. Aug. 26, 2019). Consequently, we assume the
parties' familiarity with much of the procedural and factual
- 2 - background and recite here only the information necessary to
explain our decision.1
In 1994, Vega was charged in the Superior Court of Puerto
Rico, Carolina Section, with ten counts related to various criminal
offenses. See Vega-Figueroa, slip op. at 1. Those charges
included, in relevant part: (1) unlawful possession, use, and
transportation of several guns; and (2) two counts of first-degree
murder for the deaths of Reynaldo Colón González ("Colón González")
and Melvin Flores-Montalvo ("Flores-Montalvo"). Id. On
October 11, 1995, a jury acquitted Vega of all charges. Id.
In 1997, however, a federal grand jury returned an
indictment against Vega. Id. at 2. It was alleged that Vega,
along with a co-defendant, was "in charge of an extensive criminal
enterprise involving the sale and distribution of heroin, cocaine,
crack cocaine, and marijuana" in Puerto Rico between 1990 and 1997.
Vega-Figueroa, 234 F.3d at 748. As the district court in that
case described it, the enterprise was a "very dangerous and violent
drug gang." See Vega-Figueroa, slip op. at 4. The indictment
charged Vega with various counts, including: (1) aiding and
abetting in a continuing criminal enterprise; (2) conspiring to
distribute in excess of five kilograms of heroin, in excess of
1The district court's Opinion and Order provides a more fulsome history. See United States v. Vega-Figueroa, No. 3:97-cr-00072-CVR, slip op. at 1-4 (D.P.R. Dec. 12, 2022).
- 3 - five kilograms of cocaine, and in excess of 100 kilograms of
marijuana; and (3) the unlawful use of firearms during and in
relation to a drug-trafficking offense. The indictment also listed
the aforementioned murders of Colón González and Flores-Montalvo
as overt acts in furtherance of the conspiracy. After a thirty-day
trial, the federal jury found Vega guilty on all counts.
Following the verdict, a Presentence Investigation
Report ("PSR") was prepared; it set forth a base offense level of
43. The PSR included homicide-related facts, which were the basis
for an increase in Vega's sentencing exposure under the
then-mandatory United States Sentencing Guidelines. The district
court sentenced Vega on February 19, 1999. The district court's
sentence included concurrent life sentences, one each as to Counts
One and Two, and a five-year term as to Count Three.
Shortly after sentencing, Vega appealed his conviction
and sentence to this court. See Vega-Figueroa, 234 F.3d 744. In
that appeal, Vega raised ten issues, including various evidentiary
challenges. Id. at 747-57. We affirmed Vega's conviction after
evaluating his contentions. Id. at 758. Following our decision,
Vega unsuccessfully continued to seek relief from his sentence.
See, e.g., Mot. for Retroactive Appl. of Sentencing Guidelines,
No. 3:97-cr-00072-CVR (D.P.R. May 14, 2008), ECF No. 758; Mot. to
Vacate Sentence, No. 3:97-cr-00072-CVR (D.P.R. Nov. 12, 2013), ECF
- 4 - No. 917; Mot. to Validate, No. 3:97-cr-00072-CVR (D.P.R. June 28,
2016), ECF No. 1014.
The procedural history of the present appeal is
comparatively short. Vega filed a request for compassionate
release with the Bureau of Prisons ("BOP") on May 11, 2020. There,
he emphasized his increased risk of complications from COVID-19,
given his preexisting medical conditions. On July 20, 2020, the
Warden of FCI Coleman -- FCI Coleman being the location where Vega
is incarcerated -- denied Vega's request, citing the BOP's
"extraordinary measures to contain the spread of COVID-19."2 Vega
then moved for compassionate release in the District of Puerto
Rico on February 8, 2021.
Vega's motion was brought pursuant to 18 U.S.C.
§ 3582(c)(1)(a), the provision governing sentence reductions
(colloquially known as the compassionate release provision). Vega
argued that he was entitled to relief due, in part, to the BOP's
allegedly negligent monitoring and treatment of his type 2 diabetes
and his increased risk of COVID-19-related complications due to
his diabetes. He also emphasized his "having been placed in
jeopardy twice for the same conduct on like charges (murder in the
2 Vega refers to the prison where he is housed as "FCC Coleman," while the government refers to it as "FCI Coleman." Federal Correctional Institution, Coleman, "FCI Coleman," is an Institution located within the Federal Correctional Complex, Coleman, "FCC Coleman." We adopt "FCI Coleman" here.
- 5 - first degree)." Finally, Vega asserted that his rehabilitation
efforts, analyzed under the 18 U.S.C. § 3553(a) sentencing
factors, supported a sentence reduction.
The government opposed Vega's motion, arguing that Vega
had presented neither extraordinary and compelling reasons for
compassionate release nor evidence that he was not a danger to the
community. The government pressed that Vega's health conditions
did not rise to the level of severity required under the U.S.S.G.
§ 1B1.13 policy statement.3 Further, in arguing that Vega
continued to present a danger to the community, the government
highlighted Vega's central role in the "dangerous and violent"
drug gang.4
The district court denied Vega's motion on December 12,
2022. It found that the "roughest part" of the pandemic had passed
and that the BOP "had taken necessary steps" to protect
3We have recognized the section 1B1.13 policy statement as non-binding to prisoner-initiated motions. See United States v. Ruvalcaba, 26 F.4th 14, 23 (1st. Cir. 2022). That decision held that the policy statement here was not binding for prisoner-initiated petitions. Id. The government makes clear that its briefing below relied on the policy statement as binding because it was "filed on February 19, 2021, before this Court's" Ruvalcaba decision. Our Ruvalcaba opinion issued on February 15, 2022. Id. On appeal, the government concedes that the district court incorrectly treated the section 1B1.13 policy statement as binding. 4The government also noted Vega's in-prison infractions, including his participation in a fight in 2004, his possession of a weapon in 2005, and his having not followed safety regulations in 2016.
- 6 - incarcerated individuals. It further found Vega's medical
conditions fell outside of the U.S.S.G. § 1B1.13(b) policy
statement, which it considered binding. The district court also
rejected Vega's argument on acquitted conduct, stating that
acquitted conduct could be used in making guideline
determinations. On the parties' section 3553(a) arguments, the
district court determined that, "on balance," Vega was "still a
danger to the community." It thus concluded Vega had not met the
requirements for relief under 18 U.S.C. § 3582.
This appeal followed.
II. Discussion
A. The Legal Framework
We begin our discussion with a brief explanation of the
statutory framework governing compassionate release, "[t]he First
Step Act of 2018, Pub. L. No. 115-391, 132 Stat. 5194, modified 18
U.S.C. § 3582, the compassionate release statute." United States
v. D'Angelo, 110 F.4th 42, 48 (1st Cir. 2024) (alteration in
original) (quoting 18 U.S.C. § 3582(c)(1)(A)). Under the First
Step Act, district courts may "grant prisoner-initiated
compassionate release motions once movants 'fully exhaust[]' their
administrative remedies with the BOP." Id. at 48 (alteration in
original). After administrative exhaustion, federal courts are
authorized to reduce an incarcerated individual's sentence if
(1) "extraordinary and compelling" reasons exist for doing so;
- 7 - (2) "such a reduction is consistent with applicable policy
statements issued by the Sentencing Commission;" and (3) the
sentencing factors set forth in 18 U.S.C. § 3553(a) counsel in
favor of such a reduction. Ruvalcaba, 26 F.4th at 18-19 (quoting
18 U.S.C. § 3582(c)(1)(A)) (citations omitted).
In reviewing motions for compassionate release,
"district courts enjoy broad discretion, and may conduct a holistic
review to determine whether the individualized circumstances,
taken in the aggregate, present an 'extraordinary and compelling'
reason to grant compassionate release."5 United States v.
Trenkler, 47 F.4th 42, 47 (1st Cir. 2022) (quoting Ruvalcaba, 26
F.4th at 27-28). To grant relief, the court must find that "such
a reduction is consistent with applicable policy statements issued
by the Sentencing Commission." 18 U.S.C. § 3582(c)(1)(A).
Finally, the court must "consider any applicable section 3553(a)
factors and 'determine whether, in its discretion, the
reduction . . . is warranted in whole or in part under the
particular circumstances of the case.'" Ruvalcaba, 26 F.4th at 19
5The United States Sentencing Commission has issued a policy that "extraordinary and compelling circumstances" within the meaning of 18 U.S.C. § 3582(c)(1)(A) fall into six categories. See U.S.S.G. § 1B1.13(b). Those categories are: (1) medical circumstances; (2) age; (3) family circumstances; (4) the defendant having been a "[v]ictim of [a]buse" while in custody; (5) other reasons "similar in gravity to those described in paragraphs (1) through (4);" and (6) the defendant's having "received an unusually long sentence." Id.
- 8 - (omission in original) (quoting United States v. Saccoccia, 10
F.4th 1, 4 (1st Cir. 2021)). "A district court may grant a
compassionate release motion only if it finds that the movant
satisfies each step." D'Angelo, 110 F.4th at 48 (citations
omitted).
We review a district court's denial, or grant, of a
motion for compassionate release for abuse of discretion.
Trenkler, 47 F.4th at 46 (citing Ruvalcaba, 26 F.4th at 19).
"Questions of law are reviewed de novo and findings of fact are
reviewed for clear error." Id.
B. Analysis
With this background understanding, we turn to the
parties' arguments. Vega argues that the district court erred in
its assessment of the section 3553(a) factors. He contends that
the district court wrongly concluded that leaders of
drug-trafficking organizations are categorically ineligible for
sentence reductions, even though no such categorical bar exists.
He also argues that the district court failed to consider "any and
all new" section 3553(a) factors and that a proper analysis of the
factors would show that he is not a danger to the community. 6 We
6Given our ultimate conclusion -- that the district court's analysis of the section 3553(a) factors is sound -- we decline to address the parties' arguments on the "extraordinary and compelling" reasons to either deny or grant his request for release. See United States v. Texeira-Nieves, 23 F.4th 48, 55 (1st Cir. 2022) ("[A] district court's decision to deny
- 9 - first address Vega's contention that he provided the district court
with "multiple circumstances" and 18 U.S.C. § 3553(a) factors that
were not adequately considered.7 Vega argues that the
section 3553(a) factors counsel in favor of his release. Citing
Third and Fourth Circuit opinions, he argues that the "court must
consider any and all new" section 3553(a) factors. Vega contends
that he poses a "minimum risk level" of recidivism. To support
his claim that he does not present a "danger to others," Vega
points to his age (54 years old) and his current reliance on
crutches.
By contrast, the government argues Vega has failed to
demonstrate that he is not a danger to the community. The
government highlights Vega's key role in a "very dangerous and
violent drug gang," alongside three infractions he committed while
imprisoned. The government contends that, given those
compassionate release may be affirmed solely on the basis of its supportable determination that the section 3553(a) factors weigh against the granting of such relief." (citations omitted)). There are seven section 3553(a) factors. 7 They include: (i) "the nature and circumstances of the offense and the history and characteristics of the defendant," (ii) "the need for the sentence . . . to reflect the seriousness of the offense, to promote respect for the law, and to provide just punishment for the offense," (iii) "the kinds of sentences available," (iv) the guidelines, (v) "any pertinent policy statement," (vi) "the need to avoid unwarranted sentence disparities[,]" and (vii) "the need to provide restitution to any victims." 18 U.S.C. § 3553(a); see also United States v. Fargas-Reyes, 125 F.4th 264, 269 n.3 (1st Cir. 2025) (describing "how a federal district judge approaches sentencing," including the seven section 3553(a) factors).
- 10 - circumstances, the district court was "well within its discretion
in finding that the 18 U.S.C. § 3553(a) factors weighed against
Vega's release." We agree with the government's conclusion.
Vega's argument, that a district court's review of a
motion for compassionate release must be holistic and
individualized, is sound. As we have cautioned: "[I]n conducting
their reviews, district courts should be mindful of the holistic
context of a defendant's individual case when deciding whether the
defendant's circumstances satisfy the 'extraordinary and
compelling' standard." Trenkler, 47 F.4th at 49–50. That is not
to say, however, that a district court must provide an exhaustive
explanation analyzing every factor. See United States v.
Quirós-Morales, 83 F.4th 79, 83 (1st Cir. 2023) ("[D]istrict
court[s] need not consider every potential configuration of
grounds for compassionate release but, rather, [their] analysis
'should be shaped by the arguments advanced by defendants.'"
(quoting United States v. Gonzalez, 68 F.4th 699, 706 (1st Cir.
2023))).
In fact, we have been "pellucid" in explaining "that a
district court, when conducting a section 3553(a) analysis, need
not tick off each and every factor in a mechanical sequence."
Saccoccia, 10 F.4th at 10. Indeed, "we presume -- absent some
contrary indication -- that a sentencing court considered all the
mitigating factors and that those not specifically mentioned were
- 11 - simply unpersuasive." Id. at 10 (emphasis added) (citing United
States v. Martins, 413 F.3d 139, 154 (1st Cir. 2005). Here, our
normal presumption applies, as Vega has not developed any argument
that "some contrary indication" exists. Given Vega has not made
any argument that the presumption described in Saccoccia does not
apply here, his argument fails.
The district court appropriately reviewed Vega's
rehabilitation efforts and concluded that, on balance, he still
presents a danger to the community. It stated that it
"recognize[d] [Vega's] efforts towards rehabilitation," and
referenced a quote from a "UNICOR" foreman that Vega had
"demonstrated his integrity and resolve to rehabilitative change."
See Vega-Figueroa, slip op. at 10-11. Given his crimes and prison
record, though, the district court still found that a reduction
would be inconsistent with reflecting the seriousness of the
offense, promoting respect for the law, and providing just
punishment for the offense. We have held that it is appropriate
to consider the danger an individual presents to the community
under § 3553(a)(2)(C). See D'Angelo, 110 F.4th at 50 (citations
omitted). As we recognized in D'Angelo, section 3553(a)(2)(C)
concerns "public protection, a concept that necessarily entails
the danger that a defendant poses to the community." Id.
(citations omitted). The district court's denial of Vega's motion,
based on its assessment of the danger he poses to the community,
- 12 - falls within its discretion. See id. And we find no abuse of
discretion in the district court's assessment of the
section 3553(a) factors.
Vega also argues that the district court erroneously
concluded that "leaders of drug-trafficking organizations are not
eligible for sentence reductions." In making this argument, Vega
only contends that the district court made this alleged error in
its order denying his motion for reconsideration. That order,
however, is not directly at issue on appeal, and Vega does not
advance any argument as to how the language in the denial of the
motion for reconsideration should influence our understanding of
the denial that is at issue before us. Indeed, the language in
the denial that Vega appealed differs sufficiently from the
language in the denial for reconsideration, such that Vega needed
to advance some argument explaining why the language in the
appealed denial indicates that the district court applied a
categorical bar. But, given that Vega made no such argument, we
consider this challenge waived for lack of development. See United
States v. Cortés-Maldonado, 939 F.3d 353, 355 (1st Cir. 2019)
(citing United States v. Zannino, 895 F.2d 1, 17 (1st Cir. 1990));
see also Rife v. One W. Bank, F.S.B., 873 F.3d 17, 19 (1st Cir.
- 13 - 2017) (citing Sparkle Hill, Inc. v. Interstate Mat Corp., 788 F.3d
25, 29 (1st Cir. 2015)).
III. Conclusion
For the foregoing reasons, we affirm.
- 14 -